Medicare Enrolled
Dr. Priya Oolut, M.D.
Pulmonary Disease · Sugar Land, TX
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Oolut from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Oolut?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Oolut
Dr. Priya Oolut is a pulmonary disease specialist in Sugar Land, TX, with 17 years of NPI registration. Based on federal Medicare data, Dr. Oolut performed 3,795 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Oolut received a total of $229,784 from 58 pharmaceutical and/or device companies across 803 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Oolut is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 17 years of NPI registration
▲ Top 7% volume in TX
$229,784 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗3,795
Medicare services
Top 7% in TX for pulmonary disease
Not available
Unique patients (not deduplicated)
$72
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
1,083 | $90 | $226 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
641 | $89 | $236 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
342 | $60 | $158 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
264 | $61 | $159 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
247 | $128 | $441 |
| Lung volume test using sensors A test that measures the amount of air in the lungs using sensors. |
238 | $37 | $170 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
229 | $38 | $168 |
| Expiratory airflow and volume test A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume. |
191 | $20 | $82 |
| Exercise-induced lung stress test A test performed to evaluate how the lungs function during physical exertion. It helps identify breathing difficulties or lung conditions that occur specifically when exercising. |
128 | $24 | $80 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
107 | $116 | $363 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
65 | $10 | $55 |
| Sleep study with heart rate and breathing monitoring A sleep study that monitors heart rate, breathing, airflow, and physical effort during sleep. |
64 | $38 | $246 |
| Methylprednisolone injection, up to 125 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, with a dosage of up to 125 mg. |
58 | $4 | $15 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
40 | $28 | $138 |
| Sleep study with heart rate and breathing monitoring A sleep study that monitors heart rate, breathing patterns, and sleep duration. This test records physiological data while you sleep to assess your sleep quality and breathing function. |
33 | $105 | $379 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
27 | $67 | $238 |
| Sleep study in sleep lab (age 6+) An overnight test conducted in a sleep laboratory to monitor sleep patterns and bodily functions in patients aged 6 years or older. |
21 | $126 | $517 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
17 | $132 | $316 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$229,784
Total received (2018-2024)
Avg $32,826/year across 7 years
Top 2% in TX for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
58
Companies
803
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$62,705
2023
$102,926
2022
$25,810
2021
$22,222
2020
$11,130
2019
$2,475
2018
$2,517
Payments by company (2024)
GlaxoSmithKline, LLC.
$60,234
AstraZeneca Pharmaceuticals LP
$375
Electromed, Inc.
$195
Takeda Pharmaceuticals U.S.A., Inc.
$170
Actelion Pharmaceuticals US, Inc.
$143
Boehringer Ingelheim Pharmaceuticals, Inc.
$142
GENZYME CORPORATION
$142
INTUITIVE SURGICAL, INC.
$125
Philips North America LLC
$119
HARMONY BIOSCIENCES LLC
$113
Regeneron Healthcare Solutions, Inc.
$95
ANI Pharmaceuticals, Inc.
$87
Insmed, Inc.
$77
Amgen Inc.
$74
Mylan Specialty L.P.
$62
ABBVIE INC.
$59
Janssen Pharmaceuticals, Inc
$51
Inspire Medical Systems, Inc.
$46
Optinose US, Inc.
$45
Bayer Healthcare Pharmaceuticals Inc.
$43
Mallinckrodt Hospital Products Inc.
$40
SANOFI US SERVICES INC.
$37
PFIZER INC.
$33
Baxter Healthcare
$28
Grifols USA, LLC
$26
Merck Sharp & Dohme LLC
$25
Avadel CNS Pharmaceuticals, LLC
$24
JAZZ PHARMACEUTICALS INC.
$22
Pulmonx Corporation
$22
Harmony Biosciences Llc
$18
United Therapeutics Corporation
$18
Resmed Corp
$14
Top 3 companies account for 97.0% of 2024 payments
All-time payments by company (2018-2024) ›
GlaxoSmithKline, LLC.
$217,176
AstraZeneca Pharmaceuticals LP
$1,570
Actelion Pharmaceuticals US, Inc.
$1,104
GENZYME CORPORATION
$842
Boehringer Ingelheim Pharmaceuticals, Inc.
$824
Veran Medical Technologies, Inc.
$805
Electromed, Inc.
$668
Regeneron Healthcare Solutions, Inc.
$655
Harmony Biosciences LLC
$513
Mylan Specialty L.P.
$367
Amgen Inc.
$324
Janssen Pharmaceuticals, Inc
$305
Philips Electronics North America Corporation
$293
PFIZER INC.
$271
Mallinckrodt Hospital Products Inc.
$266
JAZZ PHARMACEUTICALS INC.
$248
Insmed, Inc.
$246
Takeda Pharmaceuticals U.S.A., Inc.
$240
United Therapeutics Corporation
$197
Grifols USA, LLC
$196
Watermark Medical, Inc.
$175
OptiNose US, Inc.
$160
Optinose US, Inc.
$159
Genentech USA, Inc.
$156
ABBVIE INC.
$152
HARMONY BIOSCIENCES LLC
$151
INTUITIVE SURGICAL, INC.
$125
Philips North America LLC
$119
Circassia Pharmaceuticals Inc
$115
Inogen, Inc.
$108
Sunovion Pharmaceuticals Inc.
$98
ANI Pharmaceuticals, Inc.
$87
Gilead Sciences, Inc.
$83
Allergan Inc.
$79
Shionogi Inc
$72
Novartis Pharmaceuticals Corporation
$64
Jazz Pharmaceuticals Inc.
$59
Bayer HealthCare Pharmaceuticals Inc.
$59
Resmed Corp
$52
Merck Sharp & Dohme LLC
$49
Teva Pharmaceuticals USA, Inc.
$48
Inspire Medical Systems, Inc.
$46
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$45
Bayer Healthcare Pharmaceuticals Inc.
$43
Pulmonx Corporation
$40
SANOFI PASTEUR INC.
$38
Avadel CNS Pharmaceuticals, LLC
$38
SANOFI US SERVICES INC.
$37
Tactile Systems Technology Inc
$31
Shire North American Group Inc
$29
Baxter Healthcare
$28
Axsome Therapeutics, Inc.
$25
Nabriva Therapeutics, plc
$23
Biogen, Inc.
$22
Harmony Biosciences Llc
$18
Mallinckrodt LLC
$18
Pinnacle Biologics, Inc
$16
Fisher & Paykel Healthcare Inc
$11
Top 3 companies account for 95.7% of all-time payments
Associated products mentioned in payments ›
(2383) SleepUndivided · (8874) inCourage · (8876) Vest Therapy Und · (AK6) Vest Therapy · ACTHAR · ADVAIR · AIR 11 · AIRSENSE · AIRSUPRA · ANORO · ANORO ELLIPTA · ARALAST · ARES HOME SLEEP TESTING DEVICE · AREXVY · AVYCAZ · Adempas · AirDuo Digihaler · Arikayce · BELSOMRA · BREO · BREZTRI · BROVANA · BYDUREON · CHANTIX · CHARTIS CATHETER · DUAKLIR PRESSAIR · DUPIXENT · Da Vinci Surgical System · Dymista · ELIQUIS · EVUSHELD · Esbriet · FASENRA · FLUARIX · FLUBLOK QUADRIVALENT · FLUZONE HIGH-DOSE · Fetroja · Flexitouch Plus · GLASSIA · Hillrom - Vest System Model 105 Home Care · INOGEN ONE G3 OXYGEN CONCENTRATOR · INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH · INSPIRE · InogenOne · LONHALA MAGNAIR · LUMIZYME · LUMRYZ · LifeVest · NUCALA · OFEV · OPSUMIT · OPSUMIT MACITENTAN · ORENITRAM · Obstructive Sleep Apnea Device or Hospital Respiratory Equipment · POMPE - DISEASE · PREVNAR - 13 · PREVNAR 13 · PREVNAR 20 · PURIFIED CORTROPHIN GEL · Photofrin · ProAir Digihaler · Prolastin-C Liquid · REMODULIN · Respiratoriy Care Undiv · SMARTVEST · SPINRAZA · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · Spin · Sunosi · TEFLARO · TEZSPIRE · TRELEGY ELLIPTA · TUDORZA PRESSAIR · TYVASO · Trilogy 100 · UPTRAVI · UTIBRON · WAKIX · WINREVAIR · Wakix · Wellcentive Undiv · XARELTO · XOLAIR · XYREM · XYWAV · Xenleta · Xhance · Xolair · Xyrem · YUPELRI · Yupelri · inCourage
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Pulmonary diseases in nearby ZIP areas
108
County median income
$113,409
Nearest hospital to ZIP centroid (approximate)
HOUSTON METHODIST SUGARLAND HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Oolut is a clinical cardiology specialist, with above-average Medicare volume (top 7% in TX), with 17 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Oolut experienced with hospital follow-up visit, high complexity?
Based on Medicare claims data, Dr. Oolut performed 1,083 hospital follow-up visit, high complexity services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Oolut receive payments from pharmaceutical companies?
Yes. Dr. Oolut received a total of $229,784 from 58 companies across 803 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Oolut's costs compare to other pulmonary diseases in Sugar Land?
Dr. Oolut's average Medicare payment per service is $72. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Oolut) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Pulmonary Disease
Common procedures, typical costs, and what industry payments mean in pulmonary disease.
Same specialty & city
Pulmonary Diseases in Sugar Land
Browse pulmonary diseases in Sugar Land ranked by procedure volume and transparency data.
Highest volume
Top Pulmonary Diseases in TX
Pulmonary diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pulmonary Diseases in TX
Which TX pulmonary diseases receive the most from drug and device companies.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Actelion Pharmaceuticals US, Inc. Payments to Doctors
See all physicians who received payments from Actelion Pharmaceuticals US, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology